TG/HDL-C Ratio for Predicting Insulin Resistance in Obese Children from Beijing, China

Tian Zhang1, Fangfang Duan2, Yi Qian1

  • 1Department of Paediatric Internal Medicine, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.

Insights

The triglycerides to HDL-C ratio effectively predicts insulin resistance in obese Chinese children. Age-specific thresholds for this ratio were identified, offering a valuable biomarker for early detection.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome Research
  • Biomarker Discovery

Background:

  • International studies link the triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio with insulin resistance in overweight/obese children.
  • Limited data exists on this association specifically within the Chinese pediatric population.

Purpose of the Study:

  • To investigate the utility of the TG/HDL-C ratio as a biomarker for insulin resistance (IR) in obese children residing in Beijing.
  • To establish age-specific diagnostic thresholds for IR using the TG/HDL-C ratio in this cohort.

Main Methods:

  • A cross-sectional study involving 262 obese children from a pediatric outpatient clinic.
  • Data collection included medical history, clinical examination, and laboratory tests (blood lipids, glucose, insulin, HbA1c).
  • Children were stratified into age groups (6-9 and 10-13.5 years) and assessed for IR using the homeostatic model assessment for IR (HOMA-IR).

Main Results:

  • The TG/HDL-C ratio was significantly higher in children with IR across both age groups (p < 0.001).
  • A positive correlation was observed between the TG/HDL-C ratio and HOMA-IR in both age strata (p < 0.05).
  • Age-specific cut-off values for the TG/HDL-C ratio demonstrated moderate diagnostic accuracy (AUCs of 0.734 for 6-9 years and 0.724 for 10-13.5 years).

Conclusions:

  • The TG/HDL-C ratio serves as a practical predictor of insulin resistance in obese children in Beijing.
  • Distinct age-dependent thresholds (≥0.645 for 6-9 years; ≥0.725 for 10-13.5 years) were identified.
  • These thresholds are lower than those reported internationally, suggesting potential ethnic or environmental differences.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
509
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
136
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
184